Time to recurrence and its relation to survival after recurrence in patients resected for stage III colon cancer.
Fiche publication
Date publication
septembre 2023
Journal
European journal of cancer (Oxford, England : 1990)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BORG Christophe, Pr BOUCHE Olivier, Pr LEPAGE Côme, Dr VERNEREY Dewi
Tous les auteurs :
Rasola C, Laurent-Puig P, André T, Falcoz A, Lepage C, Aparicio T, Bouché O, Lievre A, Mineur L, Bennouna J, Louvet C, Bachet JB, Borg C, Vernerey D, Lonardi S, Taieb J
Lien Pubmed
Résumé
It is intuitively thought that early relapse is associated with poor survival after recurrence (SAR) in resected colon cancer (CC) patients, but this has never been formally studied.
Mots clés
Adjuvant, BRAF(V600E) mutation, MSI/dMMR, RAS mutation, Stage III colon cancer, Survival after relapse, Time to recurrence
Référence
Eur J Cancer. 2023 09 9;194:113321